STRATA reports record FY2022 revenue of $35-36M, up 17-19% YoY

STRATA Skin Sciences, Inc.

2023-FY EPS reported -$0.16 revenue$36,161,000

Preliminary unaudited full-year 2022 revenue of $35-36M, vs $30M in 2021.
Revenue at upper end of prior guidance of $33-35M.
Growth driven by XTRAC usage, device redeployment, and international sales.
Full audited results expected in March 2023.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

STRATA Skin Sciences, Inc. reported the 2022 fiscal year results: revenue $35-$36 million. Guidance reaffirmed.

Period: the 2022 fiscal year
Revenue: $35-$36 million
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

2 ex_99-1.htm STRATA PRESS RELEASE DATED 2/1/2023 Exhibit 99.1 STRATA Skin Sciences Expects Record Full Year 2022 Revenue ● Unaudited, preliminary revenue within the range of $35-$36 million ● Record revenue represents approximately 17-19% growth over full year 2021 HORSHAM, Pa., February 1, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:

View on SEC.gov

Browse all earnings releases →

STRATA Skin Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001051514-23-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.